Results 11 to 20 of about 1,532,463 (338)

Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019.

American Journal of Psychiatry, 2022
OBJECTIVE In the United States, adult cannabis use has increased over time, but less information is available on time trends in cannabis use disorder. The authors used Veterans Health Administration (VHA) data to examine change over time in cannabis use ...
D. Hasin, A. Saxon, C. Malte, M. Olfson, K. Keyes, J. Gradus, M. Cerdá, Charles C. Maynard, S. Keyhani, S. Martins, David S. Fink, O. Livne, Z. Mannes, M. Wall   +13 more
semanticscholar   +3 more sources

A large-scale genome-wide association study meta-analysis of cannabis use disorder

Lancet Psychiatry,the, 2020
Summary Background Variation in liability to cannabis use disorder has a strong genetic component (estimated twin and family heritability about 50–70%) and is associated with negative outcomes, including increased risk of psychopathology.
E. Johnson, D. Demontis, T. Thorgeirsson, R. Walters, R. Polimanti, A. Hatoum, S. Sanchez-Roige, S. Paul, F. Wendt, Toni‐Kim Clarke, D. Lai, Gunnar W. Reginsson, Hang Zhou, June He, D. Baranger, D. Gudbjartsson, Robbee Wedow, D. Adkins, Amy E Adkins, Jeffry C. Alexander, S. Bacanu, T. Bigdeli, J. Boden, Sandy Brown, K. Bucholz, J. Bybjerg-Grauholm, R. Corley, L. Degenhardt, D. Dick, B. Domingue, Louis Fox, A. Goate, Scott D. Gordon, L. Hack, D. Hancock, Sarah M. Hartz, I. Hickie, D. Hougaard, K. Krauter, P. Lind, J. McClintick, M. McQueen, J. Meyers, G. Montgomery, O. Mors, P. Mortensen, M. Nordentoft, J. Pearson, Roseann E. Peterson, M. Reynolds, John P. Rice, V. Runarsdottir, N. Saccone, R. Sherva, J. Silberg, R. Tarter, Thorarinn Tyrfingsson, T. Wall, B. Webb, T. Werge, L. Wetherill, Margaret J. Wright, S. Zellers, M. Adams, L. Bierut, J. Boardman, William E. Copeland, L. Farrer, T. Foroud, N. Gillespie, R. Grucza, K. Harris, A. Heath, V. Hesselbrock, J. Hewitt, Christian J. Hopfer, J. Horwood, W. Iacono, E. Johnson, K. Kendler, M. Kennedy, H. Kranzler, P. Madden, H. Maes, B. Maher, N. Martin, M. McGue, A. McIntosh, S. Medland, E. Nelson, B. Porjesz, B. Riley, M. Stallings, M. Vanyukov, S. Vrieze, L. Davis, R. Bogdan, J. Gelernter, H. Edenberg, K. Stefánsson, A. Børglum, A. Agrawal   +101 more
semanticscholar   +3 more sources

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.

Lancet Psychiatry,the, 2020
Background A substantial and unmet clinical need exists for pharmacological treatment of cannabis use disorders. Cannabidiol could offer a novel treatment, but it is unclear which doses might be efficacious or safe.
Tom P. Freeman, C. Hindocha, G. Baio, N. Shaban, Emily M Thomas, Danica Astbury, A. Freeman, R. Lees, S. Craft, P. Morrison, Michael A.P. Bloomfield, D. O'Ryan, J. Kinghorn, Celia J. A. Morgan, Ali Mofeez, H. V. Curran   +15 more
semanticscholar   +3 more sources

Cannabis Use Disorder

Nimmana BK, Aslam SP, Marwaha R.
europepmc   +4 more sources

Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications

Nature Genetics, 2023
As recreational use of cannabis is being decriminalized in many places and medical use widely sanctioned, there are growing concerns about increases in cannabis use disorder (CanUD), which is associated with numerous medical comorbidities.
D. Levey, M. Galimberti, J. Deak, Frank R Wendt, A. Bhattacharya, Dora Koller, Kelly M. Harrington, Rachel M Quaden, E. Johnson, P. Gupta, Mahantesh I. Biradar, Max Lam, Megan E. Cooke, V. Rajagopal, S. Empke, Hang Zhou, Y. Nuñez, H. Kranzler, H. Edenberg, Arpana Agrawal, J. Smoller, T. Lencz, D. Hougaard, A. Børglum, D. Demontis, J. Gaziano, Michael Jeffrey Gandal, R. Polimanti, Murray B. Stein, J. Gelernter, Veteran Program   +30 more
semanticscholar   +1 more source

Association of cannabis use disorder with cardiovascular diseases: A two-sample Mendelian randomization study

Frontiers in Cardiovascular Medicine, 2022
BackgroundThe use of cannabis has increased globally due to more regions decriminalizing marijuana use for therapeutic and recreational aims. Several observational studies have revealed that cannabis use is associated with an increased risk of adverse ...
Miao Chen, Yun-long Lu, Xiao-fan Chen, Zhen Wang, Liang Ma   +4 more
doaj   +1 more source

Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990–2019: Results from the Disease Burden Study 2019

International Journal of Mental Health and Addiction, 2023
Cannabis is the fourth psychoactive substance to be legalized which are of far-reaching significance to the world. We analyzed data from the 2019 Global Burden of Disease Study (GBD) to estimate the incidence and prevalence of cannabis use disorder (CUD)
Heng Shao, Heyue Du, Quan Gan, Dequan Ye, Zhuang-fei Chen, Yanqing Zhu, Shasha Zhu, Lang Qu, Junzuo Lu, Yutong Li, J. Duan, Yingqi Gu, Meiling Chen   +12 more
semanticscholar   +1 more source

Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal

JAMA Network Open, 2023
Key Points Question What is the prevalence of cannabis use disorder (CUD) among primary care patients who use cannabis in a state with legal recreational cannabis use, and does prevalence differ by reason for use?
Gwen T Lapham, Theresa E. Matson, J. Bobb, Casey Luce, Malia M Oliver, Leah K. Hamilton, K. Bradley   +6 more
semanticscholar   +1 more source

Prevalence of cannabis use disorder among pregnant people who test positive for cannabis at time of deliveryAJOG Global Reports at a Glance

AJOG Global Reports, 2022
BACKGROUND: Cannabis use in pregnancy is common, but the reasons that some pregnant people continue use are unclear. OBJECTIVE: This study aimed to assess the prevalence of cannabis use disorder and medicinal cannabis use among pregnant people who test ...
Cassie Wicken, MHS, Anant Walia, MS, Soroosh Solhjoo, PhD, Katrina Mark, MD, FACOG   +3 more
doaj   +1 more source

Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder.

JAMA psychiatry, 2023
Importance Cannabis use is increasing worldwide and is suspected to be associated with increased risk of psychiatric disorders; however, the association with affective disorders has been insufficiently studied. Objective To examine whether cannabis use
O. Jefsen, A. Erlangsen, M. Nordentoft, C. Hjorthøj   +3 more
semanticscholar   +1 more source